PATRICK HAWKINS: Open Payments
NPI 1902803877 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 101 payments from 11 companies in 2025. Trend: 2023 $991 · 2024 $1,008 · 2025 $1,598
Food & beverage: $1,598
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 25 | $479 |
| Lundbeck LLC | 15 | $287 |
| ABBVIE INC. | 29 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $161 |
| E.R. Squibb & Sons, L.L.C. | 10 | $148 |
| Otsuka America Pharmaceutical, Inc. | 2 | $91 |
| COLOPLAST CORP | 1 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
Products named: ARISTADA, REXULTI, CAPLYTA, COBENFY, VRAYLAR, LYBALVI, Titan, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
